Year |
Citation |
Score |
2020 |
Parker JL, Kirmiz S, Noyes SL, Davis AT, Babitz SK, Alter D, Hu S, Lane BR. Reliability of urinalysis for identification of proteinuria is reduced in the presence of other abnormalities including high specific gravity and hematuria. Urologic Oncology. PMID 32739229 DOI: 10.1016/J.Urolonc.2020.06.035 |
0.307 |
|
2020 |
Peabody H, Patel A, Johnson A, Mirza M, Noyes SL, Schervish E, Kaul S, Rogers CG, Lane BR, Semerjian A. Development of a Novel Scoring System Quantifies Opportunities to Reduce Surgery for Benign Renal Neoplasms: A Retrospective Quality Improvement Analysis within the MUSIC KIDNEY Collaborative. The Journal of Urology. 101097JU000000000000. PMID 32628102 DOI: 10.1097/Ju.0000000000001238 |
0.347 |
|
2020 |
Noyes S, Kim T, Johnson A, Linsell S, Qi J, Moldovan T, Patel AK, Ghani KR, Montie JE, Rogers CG, Lane BR. Quality of Care for Renal Masses: The Michigan Urological Surgery Improvement Collaborative—Kidney Mass: Identifying & Defining Necessary Evaluation & TherapY (MUSIC-KIDNEY) Urology Practice. DOI: 10.1097/Upj.0000000000000130 |
0.32 |
|
2020 |
Patel* A, Johnson A, Qi J, Noyes S, Schervish E, Semerjian A, Weizer A, Rogers C, Lane B. MP80-17 OBSERVATION OF T1B RENAL LESIONS IN MUSIC KIDNEY, A STATE WIDE COLLABORATIVE The Journal of Urology. 203: e1232-e1233. DOI: 10.1097/Ju.0000000000000972.017 |
0.314 |
|
2020 |
Patel* A, Johnson A, Qi J, Noyes S, Schervish E, Semerjian A, Lane B, Rogers C. MP80-16 PRACTICE PATTERNS OF RENAL MASS BIOPSY ACROSS MUSIC KIDNEY, A STATE WIDE COLLABORATIVE The Journal of Urology. 203: e1232. DOI: 10.1097/Ju.0000000000000972.016 |
0.328 |
|
2020 |
Meagher* M, Lane B, Capitanio U, Mehrazin R, Bradshaw A, Noyes S, Lacher A, Eldefrawy A, Ghali F, Keiner C, Dutt R, Miller N, Bruinius J, Patel D, Montorsi F, et al. PD49-09 COMPARATIVE ANALYSIS OF RENAL FUNCTIONAL OUTCOMES OF ACTIVE SURVEILLANCE AND PARTIAL NEPHRECTOMY IN THE MANAGEMENT OF ONCOCYTOMA The Journal of Urology. 203: e1004. DOI: 10.1097/Ju.0000000000000943.09 |
0.342 |
|
2020 |
Peabody H, Patel A, Johnson A, Mirza M, Noyes S, Schervish E, Kaul S, Rogers C, Lane B, Semerjian* A. PD49-02 CAN SURGERY FOR BENIGN RENAL NEOPLASMS BE AVOIDED COMPLETELY? A RETROSPECTIVE QUALITY IMPROVEMENT ANALYSIS WITHIN THE MUSIC KIDNEY COLLABORATIVE The Journal of Urology. 203: e1000-e1001. DOI: 10.1097/Ju.0000000000000943.02 |
0.355 |
|
2020 |
Peabody H, Murali A, Noyes S, Singh K, Lane* B. MP50-11 RISK FACTORS PREDICTING OVERALL SURVIVAL FOR PATIENTS NEWLY DIAGNOSED WITH RENAL MASSES The Journal of Urology. 203: e757. DOI: 10.1097/Ju.0000000000000912.011 |
0.324 |
|
2020 |
Bradshaw* A, Uzzo R, Capitanio U, Lane B, Patil D, Saito K, Ghali F, Kutikov A, Larcher A, Noyes S, Dutt R, Keiner C, Miller N, Wan F, Meagher M, et al. PD11-05 MULTICENTER COMPARISON OF OUTCOMES FOR CLINICAL AND PATHOLOGIC T3A RENAL CELL CARCINOMA The Journal of Urology. 203: e254-e255. DOI: 10.1097/Ju.0000000000000845.05 |
0.335 |
|
2019 |
Bruinius JW, Dykema KJ, Noyes SL, Teh BT, Lane BR. Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment? Case Reports in Urology. 2019: 2479823. PMID 31956465 DOI: 10.1155/2019/2479823 |
0.344 |
|
2019 |
Dey S, Noyes SL, Uddin G, Lane BR. Palpable Abdominal Mass is a Renal Oncocytoma: Not All Large Renal Masses are Malignant. Case Reports in Urology. 2019: 6016870. PMID 31485367 DOI: 10.1155/2019/6016870 |
0.361 |
|
2019 |
Johnson K, Herrel L, Johnson A, Kim T, Qi J, Rogers C, Sarle R, Lane B. Pd67-06 Is Outpatient Classification Justified For Minimally-Invasive Renal Surgery? Results From A Statewide Quality Improvement Collaborative The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557480.62280.Fd |
0.329 |
|
2019 |
Johnson K, Weizer A, Johnson A, Kaul S, Kim T, Montie J, Pinson T, Prebay Z, Qi J, Rogers C, Traver M, Lane B. Pd58-08 A Statewide Quality Improvement Collaborative’S Adherence To 2017 Aua Guidelines Regarding Initial Evaluation Of Renal Masses The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557176.20097.39 |
0.314 |
|
2019 |
Meagher M, Lane B, Bradshaw A, Noyes S, Eldefrawy A, Cotta B, Patel S, Bruinius J, Ryan S, Wan F, Derweesh I. Mp42-19 Comparison Of Renal Functional Outcomes Of Active Surveillance And Partial Nephrectomy In The Management Of Oncocytoma The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556222.12045.9D |
0.345 |
|
2019 |
Patel* S, Reddy M, Uzzo R, Larcher A, Bindayi A, Ryan S, Yim K, Nasseri R, Hamilton Z, Peyronnet B, Wang F, Lane B, Pruthi D, Capitanio U, Kutikov A, et al. MP42-17 ONCOLOGIC AND FUNCTIONAL OUTCOMES OF RADICAL AND PARTIAL NEPHRECTOMY IN PT3A PATHOLOGICALLY UPSTAGED RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556220.04421.F8 |
0.357 |
|
2019 |
Bradshaw* A, Lane B, Larcher A, Patil D, Meagher M, Capitanio U, Noyes S, Eldefrawy A, Cotta B, Bruinius J, Ryan S, Wan F, Montorsi F, Master V, Derweesh I. MP20-18 COMPARISON OF RENAL FUNCTIONAL OUTCOMES OF PARTIAL NEPHRECTOMY VS. ANGIOEMBOLIZATION IN THE TREATMENT OF ANGIOMYOLIPOMA: A MULTICENTER ANALYSIS Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555526.72128.E9 |
0.365 |
|
2018 |
Klingler MJ, Babitz SK, Kutikov A, Campi R, Hatzichristodoulou G, Sanguedolce F, Brookman-May S, Akdogan B, Capitanio U, Roscigno M, Volpe A, Marszalek M, Uzzo RG, Antonelli A, Langenhuijsen J, ... ... Lane BR, et al. Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study. Urologic Oncology. PMID 30473205 DOI: 10.1016/J.Urolonc.2018.11.007 |
0.362 |
|
2018 |
Lane BR, Babitz SK, Vlasakova K, Wong A, Noyes SL, Boshoven W, Grady P, Zimmerman C, Engerman S, Gebben M, Tanen M, Glaab WE, Sistare FD. Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study. European Urology Focus. PMID 30425001 DOI: 10.1016/J.Euf.2018.10.017 |
0.329 |
|
2018 |
Gupta R, Tori M, Babitz SK, Tobert CM, Anema JG, Noyes SL, Lane BR. Comparison of RENAL, PADUA, CSA, and PAVP Nephrometry Scores in Predicting Functional Outcomes after Partial Nephrectomy. Urology. PMID 30107186 DOI: 10.1016/J.Urology.2018.03.055 |
0.344 |
|
2018 |
Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, ... ... Lane BR, et al. Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]. European Urology. PMID 29853305 DOI: 10.1016/J.Eururo.2018.05.017 |
0.306 |
|
2018 |
Tobert CM, Lane BR. Growth spurts of small renal masses correlate with pathology. Bju International. 121: 678-679. PMID 29687950 DOI: 10.1111/Bju.14154 |
0.312 |
|
2018 |
Wu J, Suk-Ouichai C, Dong W, Caraballo ER, Derweesh IH, Lane BR, Demirjian S, Li J, Campbell SC. PD07-07 CHRONIC KIDNEY DISEASE PRIMARILY RELATED TO RENAL CANCER SURGERY: IMPLICATIONS FOR SURVIVAL Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.440 |
0.358 |
|
2018 |
Rogers C, Kim T, Noyes S, Kaul S, Qi J, Ghani K, Montie J, Miller D, Weizer A, Lane B, Surgery Improvement Collaborative ftMU. PD51-11 INSTITUTION OF A SMALL RENAL MASS QUALITY IMPROVEMENT INITIATIVE IN A STATEWIDE COLLABORATIVE Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.2351 |
0.313 |
|
2018 |
Lane B, Weizer A, Kim T, Qi J, Kaul S, Schervish E, Stockton B, Rogers C, Surgery Improvement Collaborative ftMU. MP59-18 USE OF SURVEILLANCE VERSUS ACTIVE TREATMENT FOR RENAL MASSES ≤7 CM: RESULTS FROM THE MUSIC KIDNEY REGIONAL COLLABORATIVE Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1870 |
0.339 |
|
2018 |
Ristau B, Derweesh I, Hamilton Z, DeMora L, Field C, Block A, Berquist S, Greenberg R, Viterbo R, Chen D, Smaldone M, Kutikov A, Lane B, Uzzo R. MP48-09 SAFE AND EFFECTIVE PARTIAL NEPHRECTOMY IS FEASIBLE IN APPROPRIATELY SELECTED PATIENTS WITH COMPLEX (RENAL NEPHROMETRY SCORE 10-12) RENAL TUMORS: A MULTI-INSTITUTIONAL ANALYSIS Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1508 |
0.364 |
|
2018 |
Martin C, Mayer E, Uzzo R, Lane B, Kutikov A, Smaldone M, Gee J, Karsh L, Gardner T, Master V, Holzbeierlein J, Lowrance W. MP42-11 EXCESSIVE RISKS FOR DEVELOPING RENAL FAILURE AFTER CYTOREDUCTIVE NEPHRECTOMY IN THE METASTATIC SETTING Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1318 |
0.325 |
|
2017 |
Zabell J, Demirjian S, Lane BR, Derweesh IH, Isharwal S, Suk-Ouichai C, Wu J, Palacios DA, Campbell SC. Predictors of Long-term Survival after Renal Cancer Surgery. The Journal of Urology. PMID 28859893 DOI: 10.1016/J.Juro.2017.08.096 |
0.357 |
|
2017 |
Wu J, Suk-Ouichai C, Dong W, Antonio EC, Derweesh IH, Lane BR, Demirjian S, Li J, Campbell SC. Analysis of Survival for Patients with Chronic Kidney Disease Primarily Related to Renal Cancer Surgery. Bju International. PMID 28834125 DOI: 10.1111/Bju.13994 |
0.358 |
|
2017 |
Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, ... ... Lane BR, et al. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. European Urology. PMID 28797570 DOI: 10.1016/J.Eururo.2017.07.015 |
0.323 |
|
2017 |
Dey S, Peabody HN, Noyes SL, Lane BR. Neoadjuvant Targeted Molecular Therapy Before Renal Surgery. The Urologic Clinics of North America. 44: 289-303. PMID 28411920 DOI: 10.1016/J.Ucl.2016.12.014 |
0.339 |
|
2017 |
Dey S, Hamilton Z, Noyes SL, Tobert CM, Keeley J, Derweesh IH, Lane BR. Chronic Kidney Disease is More Common in Locally-Advanced Renal Cell Carcinoma. Urology. PMID 28365357 DOI: 10.1016/J.Urology.2017.03.033 |
0.375 |
|
2017 |
Bezinque A, Noyes SL, Kirmiz S, Parker J, Dey S, Kahnoski RJ, Lane BR. Prevalence of Proteinuria and Other Abnormalities in Urinalysis Performed in the Urology Clinic. Urology. PMID 28212852 DOI: 10.1016/J.Urology.2017.02.011 |
0.338 |
|
2017 |
Hamilton Z, Larcher A, Lane B, Capitanio U, Dey S, Bloch A, Field C, Kirmiz S, Han D, Bezinque A, Beksac AT, Carenzi C, Wan F, Proudfoot J, Montorsi F, et al. MP72-03 COMPARATIVE ANALYSIS OF RADICAL AND PARTIAL NEPHRECTOMY IN PATIENTS WITH PREOPERATIVE STAGE 2 CHRONIC KIDNEY DISEASE: A MULTICENTER STUDY Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2239 |
0.318 |
|
2017 |
Hamilton Z, Han D, Beksac AT, Berquist S, Hassan A, Field C, Bloch A, Dey S, Bezinque A, Kirmiz S, Wan F, Proudfoot J, Patterson A, Akdogan B, Ozen H, ... Lane B, et al. MP67-07 PATHOLOGICAL DETERMINANTS OF ONCOLOGIC OUTCOMES IN STAGE II RENAL CELL CARCINOMA: AN INTERNATIONAL MULTICENTER ANALYSIS Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2043 |
0.331 |
|
2017 |
Zattoni F, Thompson R, Capitano U, Crestani A, Ficarra V, Kutikov A, Larcher A, Lane B, Leibovich B, McIntosh A, Montorsi F, Moon D, Muilwijk T, Murray K, Noyes S, et al. Partial nephrectomy in the treatment of renal tumors with concomitant venous tumor thrombosis (VTT) of renal vein branches: Retrospective, multi-center analysis of perioperative, functional, and oncologic outcomes European Urology Supplements. 16: e1832-e1833. DOI: 10.1016/J.Juro.2017.02.1698 |
0.353 |
|
2016 |
Bezinque A, Lane BR. Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors. Annals of Surgical Oncology. PMID 27401450 DOI: 10.1245/S10434-016-5413-Y |
0.322 |
|
2016 |
O'Donnell K, Tourojman M, Tobert CM, Kirmiz SW, Riedinger CB, Demirjian S, Lane BR. Proteinuria is a Predictor of Renal Functional Decline in Kidney Cancer Patients. The Journal of Urology. PMID 27018509 DOI: 10.1016/J.Juro.2016.03.134 |
0.369 |
|
2016 |
Mayer EN, Lowrance WT, Uzzo R, Wood C, Kutikov A, Smaldone M, Gee J, Huang W, Gardner T, Bratslavsky G, Holzbeierlein J, Karsh L, Master V, Shore N, Lane B. PD04-02 RENAL FUNCTION BEFORE AND AFTER CYTOREDUCTIVE NEPHRECTOMY IN A PHASE 3 RANDOMIZED CLINICAL TRIAL Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2407 |
0.308 |
|
2015 |
Kuusk T, Biancari F, Lane B, Tobert C, Campbell S, Rimon U, D'Andrea V, Mehik A, Vaarala MH. Treatment of renal angiomyolipoma: pooled analysis of individual patient data. Bmc Urology. 15: 123. PMID 26710923 DOI: 10.1186/S12894-015-0118-2 |
0.349 |
|
2015 |
Tourojman M, Kirmiz S, Boelkins B, Noyes SL, Davis AT, O'Donnell K, Tobert CM, Lane BR. Impact of reduced GFR and proteinuria on overall survival of renal cancer patients. The Journal of Urology. PMID 26433140 DOI: 10.1016/J.Juro.2015.09.083 |
0.354 |
|
2015 |
Tobert CM, Takagi T, Liss MA, Lee H, Derweesh IH, Campbell SC, Lane BR. Multicenter Validation of Surgeon Assessment of Renal Preservation in Comparison to Measurement With 3D Image Analysis. Urology. 86: 534-8. PMID 26144341 DOI: 10.1016/J.Urology.2015.06.014 |
0.363 |
|
2015 |
Lane BR, Demirjian S, Derweesh IH, Takagi T, Zhang Z, Velet L, Ercole CE, Fergany AF, Campbell SC. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate. European Urology. 68: 996-1003. PMID 26012710 DOI: 10.1016/J.Eururo.2015.04.043 |
0.361 |
|
2015 |
Farrell C, Noyes SL, Tourojman M, Lane BR. Renal angiomyolipoma: preoperative identification of atypical fat-poor AML. Current Urology Reports. 16: 12. PMID 25677233 DOI: 10.1007/S11934-015-0484-Z |
0.351 |
|
2015 |
Lane BR, Derweesh IH, Kim HL, O'Malley R, Klink J, Ercole CE, Palazzi KL, Thomas AA, Rini BI, Campbell SC. Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma. Urologic Oncology. 33: 112.e15-21. PMID 25532471 DOI: 10.1016/J.Urolonc.2014.11.009 |
0.361 |
|
2015 |
Lee H, Jimenez J, Wang S, Raheem O, Gillis K, Alagh A, Kane CJ, LIss M, Millard F, Lane B, Campbell S, Derweesh I. MP69-14 PERIOPERATIVE AND RENAL FUNCTIONAL OUTCOMES OF PARTIAL NEPHRECTOMY FOR COMPLEX RENAL SCORE WITH OR WITHOUT PRE-SURGICAL SUNITINIB: A MULTICENTER ANALYSIS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2518 |
0.323 |
|
2015 |
Lee H, Jimenez J, Wang S, Raheem O, Gillis K, Alagh A, Kane CJ, LIss M, Millard F, Lane B, Campbell S, Derweesh I. PD35-12 NEOADJUVANT SUNITINIB IS ASSOCIATED WITH IMPROVED ONCOLOGIC OUTCOMES FOR PATIENTS WITH TUMOR THROMBUS IN RENAL CELL CARCINOMA: A MULTICENTER ANALYSIS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2235 |
0.32 |
|
2015 |
Best S, Blute M, Lane B, Abel EJ. MP59-04 OPTIMAL TREATMENT FOR 4-10CM RENAL CELL CARCINOMA: A SURVEY OF ENDOUROLOGISTS AND UROLOGIC ONCOLOGISTS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2164 |
0.318 |
|
2015 |
Tobert C, Takagi T, Liss M, Lee H, Derweesh I, Campbell S, Lane B. MP84-09 MULTICENTER VALIDATION OF ABILITY OF SURGEON ASSESSMENT OF RENAL PRESERVATION IN COMPARISON TO MEASUREMENT WITH 3D IMAGE ANALYSIS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1976 |
0.304 |
|
2015 |
Tourojman M, Noyes S, O'Donnell K, Kirmiz S, Tobert C, Boelkins B, Ghareeb G, Giovanucci J, Lane B. MP44-19 IMPACT OF REDUCED GFR AND PROTEINURIA ON OVERALL SURVIVAL OF RENAL CANCER PATIENTS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1561 |
0.35 |
|
2015 |
O'Donnell K, Tobert C, Boelkins B, Noyes S, Kirmiz S, Tourojman M, Ghareeb G, Giovanucci J, Demirjian S, Lane B. MP44-02 IS GFR ENOUGH TO DEFINE CHRONIC KIDNEY DISEASE IN KIDNEY CANCER PATIENTS? Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1544 |
0.326 |
|
2014 |
Demirjian S, Lane BR, Derweesh IH, Takagi T, Fergany A, Campbell SC. Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival. The Journal of Urology. 192: 1057-62. PMID 24747655 DOI: 10.1016/J.Juro.2014.04.016 |
0.334 |
|
2014 |
Tobert CM, Riedinger CB, Lane BR. Do we know (or just believe) that partial nephrectomy leads to better survival than radical nephrectomy for renal cancer? World Journal of Urology. 32: 573-9. PMID 24671608 DOI: 10.1007/S00345-014-1275-8 |
0.342 |
|
2014 |
Lee H, Derweesh I, Tobert C, Patel N, Liss M, Mehrazin R, Wang S, Patterson A, Lane B. PIII-02 MULTICENTER ANALYSIS OF DIAGNOSTIC ACCURACY OF PERCUTANEOUS RENAL MASS BIOPSY IN PATIENTS PRIOR TO RENAL EXTIRPATIVE SURGERY AND EXTERNAL VALIDATION OF MICHIGAN RENAL BIOPSY RISK STRATIFICATION ALGORITHM Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2046 |
0.348 |
|
2014 |
Ercole C, Lane B, Kim H, Derweesh I, O'Malley R, Klink J, Palazzi K, Rini B, Campbell S. MP64-13 NON-METASTATIC RENAL CANCERS OF MODERATE TO HIGH COMPLEXITY ARE AMENABLE TO PARTIAL NEPHRECTOMY AFTER NEOADJUVANT SUNITINIB Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1930 |
0.339 |
|
2013 |
Weight CJ, Miller DC, Campbell SC, Derweesh IH, Lane BR, Messing EM. The management of a clinical t1b renal tumor in the presence of a normal contralateral kidney. The Journal of Urology. 189: 1198-202. PMID 23337186 DOI: 10.1016/J.Juro.2013.01.030 |
0.334 |
|
2013 |
Lane BR, Campbell SC, Gill IS. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy. The Journal of Urology. 190: 44-9. PMID 23306087 DOI: 10.1016/J.Juro.2012.12.102 |
0.343 |
|
2013 |
Lane BR, Campbell SC, Demirjian S, Fergany AF. Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease. The Journal of Urology. 189: 1649-55. PMID 23201493 DOI: 10.1016/J.Juro.2012.11.121 |
0.353 |
|
2013 |
Hobbs DJ, Zhou M, Campbell SC, Aydin H, Weight CJ, Lane BR. The impact of location and number of cores on the diagnostic accuracy of renal mass biopsy: an ex vivo study. World Journal of Urology. 31: 1159-64. PMID 22527673 DOI: 10.1007/S00345-012-0868-3 |
0.317 |
|
2013 |
Tobert CM, Uzzo RG, Wood CG, Lane BR. Adjuvant and neoadjuvant therapy for renal cell carcinoma: a survey of the Society of Urologic Oncology. Urologic Oncology. 31: 1316-20. PMID 22264501 DOI: 10.1016/J.Urolonc.2011.12.014 |
0.313 |
|
2013 |
Lane BR. Molecular markers of kidney injury. Urologic Oncology. 31: 682-5. PMID 21723753 DOI: 10.1016/J.Urolonc.2011.05.007 |
0.32 |
|
2012 |
Tobert CM, Kahnoski RJ, Thompson DE, Anema JG, Kuntzman RS, Lane BR. RENAL nephrometry score predicts surgery type independent of individual surgeon's use of nephron-sparing surgery. Urology. 80: 157-61. PMID 22626579 DOI: 10.1016/J.Urology.2012.03.025 |
0.332 |
|
2012 |
Thompson RH, Lane B, Lohse C, Leibovich B, Fergany A, Frank I, Blute M, Gill I, Campbell S. 1683 DO PATIENTS WITH NORMAL RENAL FUNCTION TOLERATE LONGER PERIODS OF WARM ISCHEMIA DURING PARTIAL NEPHRECTOMY COMPARED WITH PATIENTS HARBORING CHRONIC KIDNEY DISEASE? Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1556 |
0.346 |
|
2011 |
Lane BR, Chen H, Morrow M, Anema JG, Kahnoski RJ. Increasing use of kidney sparing approaches for localized renal tumors in a community based health system: impact on renal functional outcomes. The Journal of Urology. 186: 1229-35. PMID 21849192 DOI: 10.1016/J.Juro.2011.05.081 |
0.363 |
|
2011 |
Lane BR. What is the best method of preoperatively determining the management of small renal masses? The Journal of Urology. 186: 12-3. PMID 21571330 DOI: 10.1016/J.Juro.2011.04.027 |
0.317 |
|
2011 |
Lane BR, Gill IS, Fergany AF, Larson BT, Campbell SC. Limited warm ischemia during elective partial nephrectomy has only a marginal impact on renal functional outcomes. The Journal of Urology. 185: 1598-603. PMID 21419452 DOI: 10.1016/J.Juro.2010.12.046 |
0.35 |
|
2011 |
Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love TE, Campbell SC. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. The Journal of Urology. 185: 421-7. PMID 21167524 DOI: 10.1016/J.Juro.2010.09.131 |
0.356 |
|
2011 |
Ching C, Lane B, Novick AC, Campbell SC, Fergany A. 1091 5 AND 10 YEAR FOLLOW-UP OF OPEN PARTIAL NEPHRECTOMY IN A SOLITARY KIDNEY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1129 |
0.317 |
|
2011 |
Thompson RH, Lane B, Lohse C, Leibovich B, Fergany A, Frank I, Gill I, Blute M, Campbell S. 1090 EVALUATION OF MODIFIABLE AND NON-MODIFIABLE FEATURES ASSOCIATED WITH RENAL FUNCTION FOLLOWING PARTIAL NEPHRECTOMY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1128 |
0.329 |
|
2010 |
Lane BR, Fergany AF, Weight CJ, Campbell SC. Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy. The Journal of Urology. 184: 1286-90. PMID 20723936 DOI: 10.1016/J.Juro.2010.06.011 |
0.384 |
|
2010 |
Lane BR, Campbell SC. Is radical nephrectomy overused in elderly kidney cancer patients? Aging Health. 6: 587-589. DOI: 10.2217/Ahe.10.50 |
0.322 |
|
2010 |
Weight C, Lieser G, Larson B, Lygothe C, Lane B, Campbell S, Kaouk J, Gill I, Fergany A. 1241 PATHOLOGICAL UPSTAGING DOES NOT AFFECT SURVIVAL IN PATIENTS WITH PT2/T3 RENAL TUMORS TREATED BY EITHER PARTIAL NEPHRECTOMY (PN) OR RADICAL NEPHRECTOMY (RN) Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.785 |
0.335 |
|
2010 |
Lane B, Gill I, Larson B, Campbell S. 995 THE USE OF WARM ISCHEMIA DURING PARTIAL NEPHRECTOMY IN A PATIENT WITH TWO FUNCTIONING KIDNEYS HAS LITTLE IMPACT ON RENAL FUNCTIONAL OUTCOMES Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.1964 |
0.351 |
|
2009 |
Lane BR, Campbell SC. Editorial comment. Value of frozen section analysis of enlarged lymph nodes during radical nephrectomy for renal cell carcinoma. Urology. 74: 368-9; author reply . PMID 19646622 DOI: 10.1016/J.Urology.2009.01.063 |
0.301 |
|
2009 |
Lane BR, Abouassaly R, Novick AC, Gill IS, Hernandez AV, Kaouk JH, Weight CJ, Larson BT, Campbell SC. ACTIVE TREATMENT OF LOCALIZED RENAL TUMORS MAY NOT IMPACT OVERALL SURVIVAL IN PATIENTS 75 YEARS OF AGE OR OLDER WITH MEDICAL COMORBIDITY Journal of Urology. 181: 320-320. DOI: 10.1016/S0022-5347(09)60911-3 |
0.306 |
|
2008 |
Lane BR, Campbell SC, Aydin H, Weight CJ, Zhou M. THE IMPACT OF NUMBER AND LOCATION OF CORES ON THE DIAGNOSTIC ACCURACY OF RENAL MASS BIOPSY: AN EX VIVO STUDY Journal of Urology. 179: 477-478. DOI: 10.1016/S0022-5347(08)61403-2 |
0.317 |
|
2007 |
Lane BR, Novick AC. 648: Comparison of Laparoscopic and Open Partial Nephrectomy for a Single Renal Tumor in a Solitary Kidney Journal of Urology. 177: 217-218. DOI: 10.1016/S0022-5347(18)30888-7 |
0.359 |
|
2007 |
Nguyen CT, Lane BR, Hegarty NJ, Kaouk JH, Gill IS, Novick AC, Campbell SC. 635: Management of Renal Cell Carcinoma Recurrence after PRIOR Thermal Ablative Therapy Journal of Urology. 177: 213-213. DOI: 10.1016/S0022-5347(18)30875-9 |
0.314 |
|
2007 |
Thomas A, Lane BR, Rini BI, Campbell SC. 502: Effect of Sunitinib in Patients with Unresectable Primary Renal Cell Carcinoma Journal of Urology. 177: 167-168. DOI: 10.1016/S0022-5347(18)30742-0 |
0.347 |
|
2007 |
Weight CJ, Kaouk JH, Hegarty NJ, Lane BR, Remer EM, O'Malley CM, Gill IS, Novick AC. 497: MRI is Inadequate for Monitoring Renal Tumor Destruction Following Radio Frequency Ablation Journal of Urology. 177: 166-166. DOI: 10.1016/S0022-5347(18)30737-7 |
0.307 |
|
2006 |
Hegarty NJ, Lane BR, Aron M, Chung BI, Desai MM. 1112: Oncological Results Following Percutaneous Resection of Upper Tract Transitional Cell Carcinoma in Patients with a Solitary Kidney Journal of Urology. 175: 358-358. DOI: 10.1016/S0022-5347(18)33337-8 |
0.312 |
|
2003 |
Lane BR, King SR, Bock PJ, Strieter RM, Coffey MJ, Markovitz DM. The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology. 307: 122-34. PMID 12667820 DOI: 10.1016/S0042-6822(02)00045-4 |
0.59 |
|
2003 |
Faulkner NE, Lane BR, Bock PJ, Markovitz DM. Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate. Journal of Virology. 77: 2276-81. PMID 12525665 DOI: 10.1128/Jvi.77.3.2276-2281.2003 |
0.731 |
|
2002 |
Lane BR, Liu J, Bock PJ, Schols D, Coffey MJ, Strieter RM, Polverini PJ, Markovitz DM. Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. Journal of Virology. 76: 11570-83. PMID 12388718 DOI: 10.1128/Jvi.76.22.11570-11583.2002 |
0.579 |
|
2002 |
Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cellular Immunology. 215: 61-71. PMID 12142037 DOI: 10.1016/S0008-8749(02)00017-5 |
0.596 |
|
2002 |
Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. The Journal of Biological Chemistry. 277: 16913-9. PMID 11847231 DOI: 10.1074/Jbc.M200875200 |
0.597 |
|
2001 |
Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, Strieter RM, Markovitz DM. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. Journal of Virology. 75: 8195-202. PMID 11483765 DOI: 10.1128/Jvi.75.17.8195-8202.2001 |
0.585 |
|
2001 |
Lane BR, Strieter RM, Coffey MJ, Markovitz DM. Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes. Journal of Virology. 75: 5812-22. PMID 11390582 DOI: 10.1128/Jvi.75.13.5812-5822.2001 |
0.59 |
|
2001 |
Browning CM, Smith MJ, Clark NM, Lane BR, Parada C, Montano M, KewalRamani VN, Littman DR, Essex M, Roeder RG, Markovitz DM. Human GLI-2 is a tat activation response element-independent Tat cofactor. Journal of Virology. 75: 2314-23. PMID 11160734 DOI: 10.1128/Jvi.75.5.2314-2323.2001 |
0.584 |
|
2001 |
Smith MJ, Gitlin SD, Browning CM, Lane BR, Clark NM, Shah N, Rainier S, Markovitz DM. GLI-2 modulates retroviral gene expression. Journal of Virology. 75: 2301-13. PMID 11160733 DOI: 10.1128/Jvi.75.5.2301-2313.2001 |
0.564 |
|
1999 |
Lane BR, Markovitz DM, Woodford NL, Rochford R, Strieter RM, Coffey MJ. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. Journal of Immunology (Baltimore, Md. : 1950). 163: 3653-61. PMID 10490959 |
0.539 |
|
Show low-probability matches. |